We are the first and only biotechnology company in Lithuania manufacturing advanced therapy medicinal products (ATMPs) individually for each patient. We develop our products by using patients’ own tissues and cells in the manufacturing process, and by addressing the specific needs of each person. All our processes are carried out using the most advanced technologies […]
In mid-2015, we established our laboratory for the manufacture of ATMPs, in accordance with Good Manufacturing Practice requirements and procedures for the production of ATMPs approved by the Ministry of Health. We currently use this laboratory to produce ATMPs such as a dendritic cell vaccine for use in cancer immunotherapy and a T-cell product for […]Read more
One of our services is the preparation of stromal vascular fraction cells (SVF) from adipose tissue for the use in therapy. SVF can be used to help regenerate articular cartilage tissues, restore damaged or sagging skin, or can participate in new vascular network formation in patients with critical limb ischemia. The tissue bank collects, processes, […]Read more
In April 2016, we opened the doors of a scientific laboratory that now operates 24 hours a day. We conduct research into methods of cancer immunotherapy using cell-derived products in collaboration with our partners from Lithuania, Austria, Estonia and the Czech Republic. Our research partners include National Cancer Institute, Joint Life Sciences Centre, State […]Read more
Cancer immunotherapy using a dendritic cell vaccine (DCV) is a supplementary cancer treatment method, created individually for each patient.
Read more
Individually for each patient developed stem cell preparation, which restore the functions of many types of damaged tissue.
Read more
T-cell preparation allow a doctor to stop the immune system’s response to the nerve-covering insulating layer of myelin.
Read more
09/20/2017
By using stem cells, 13 patients with gangrening limbs were protected from amputation and it was the first time in the history of medicine of Lithuania. This result was reached after the scientists and doctors of our country performed experimental research together and succeeded in treating 87 per cent patients having suffered from critical limb […]
Read more
09/20/2017
Presently, “Froceth”, JSC and the National Institute of Cancer are implementing the project “Medical products modulating the advanced therapy immune system for the treatment of cancer” that is co-funded with the support of the European Fund of Regional Development provided according to the Programme of Investment Actions of the EU-Funds 2014–2020.
Read more
09/20/2017
Lithuanian scientists started scientific research planning to develop world-unique cancer immunotherapy products. Especially advanced medical products will be manufactured by using exosomes in the process of saturation of dendritic cells with tumour antigens.
Read more
